GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huons Global Co Ltd (XKRX:084110) » Definitions » EV-to-EBIT

Huons Global Co (XKRX:084110) EV-to-EBIT : 1.54 (As of May. 04, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Huons Global Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Huons Global Co's Enterprise Value is ₩201,317 Mil. Huons Global Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩130,568 Mil. Therefore, Huons Global Co's EV-to-EBIT for today is 1.54.

The historical rank and industry rank for Huons Global Co's EV-to-EBIT or its related term are showing as below:

XKRX:084110' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.5   Med: 10.54   Max: 75.77
Current: 1.53

During the past 13 years, the highest EV-to-EBIT of Huons Global Co was 75.77. The lowest was 1.50. And the median was 10.54.

XKRX:084110's EV-to-EBIT is ranked better than
97% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs XKRX:084110: 1.53

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Huons Global Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩632,828 Mil. Huons Global Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩130,568 Mil. Huons Global Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 20.63%.


Huons Global Co EV-to-EBIT Historical Data

The historical data trend for Huons Global Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huons Global Co EV-to-EBIT Chart

Huons Global Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 4.66 9.06 34.71 4.81

Huons Global Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.71 20.88 13.75 10.89 4.81

Competitive Comparison of Huons Global Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Huons Global Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huons Global Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huons Global Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Huons Global Co's EV-to-EBIT falls into.



Huons Global Co EV-to-EBIT Calculation

Huons Global Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=201316.812/130567.507
=1.54

Huons Global Co's current Enterprise Value is ₩201,317 Mil.
Huons Global Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩130,568 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huons Global Co  (XKRX:084110) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Huons Global Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=130567.507/632828.144
=20.63 %

Huons Global Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩632,828 Mil.
Huons Global Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩130,568 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huons Global Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Huons Global Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Huons Global Co (XKRX:084110) Business Description

Traded in Other Exchanges
N/A
Address
901, Pangyo Innovalley C, 621, Sampyeong-dong Bundang-gu, Gyeonggi-do, KOR, 153-788
Huons Global Co Ltd is active in the healthcare sector. Its primary business includes the manufacture and sale of pharmaceutical products. The company functions through three divisions; pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division represents the production of ethical drugs like the local anesthetic. The medical devices division is engaged in developing devices to aid safe preparation of platelet-poor plasma and platelet concentrate from the sample of blood. The company's suite of cosmetic products comprises of cleansers, creams, and sunscreens.

Huons Global Co (XKRX:084110) Headlines

No Headlines